Menu

Orchestra BioMed Holdings, Inc. OBIO

Full chart Compare
Set alert

Price alert · OBIO

All alert types
5.68 USD +0.06 (+1.07%)

At closeNov 6, 2026, 4:27 PM EST

5.68 0.00 0.00%

After hours · Nov 6, 4:27 PM ET

5.14 Day range 6.04
3.49 52-week range 6.35
YTD
+36.87%
1 year
+49.08%

Revenue & Expenses

Other Income → Expenses: $254.00KExpenses → Selling, General & Admin: $26.91MExpenses → Research & Development: $58.19MExpenses → Interest Expense: $1.15MGross Profit → Expenses: $33.29MRevenue → Gross Profit: $33.29MRevenue → Cost of Revenue: $190.00KNet Loss → Expenses: $52.70MOther Income$254.00KGross Profit$33.29MNet Loss$52.70MCost of Revenue$190.00KExpenses$86.25MSelling, General & Admin$26.91MResearch & Development$58.19MInterest Expense$1.15MRevenue$33.48M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

OBIO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
33.48M2.64M2.76M3.53M-782.00K
33.48M2.64M2.76M3.53M-782.00K
190.00K204.00K186.00K211.00K199.00K
33.29M2.43M2.57M3.32M-981.00K
85.10M66.73M54.08M35.98M20.82M
58.19M42.80M33.82M21.95M12.89M
26.91M23.93M20.26M14.03M7.93M
-51.81M-64.30M-51.51M-32.66M-21.80M
1.15M-3.36M00927.00K
-52.70M-61.02M-49.12M-33.61M-23.01M
-52.95M-61.02M-49.12M-33.61M-23.01M
-52.95M-61.02M-49.12M-33.61M-23.01M
-52.70M-61.02M-49.12M-33.61M-23.01M
-1.11-1.66-1.48-2.24-2.61
-1.11-1.66-1.48-2.24-2.61
-1.11-1.66-1.48-2.24-2.61
-51.55M-64.38M-49.12M-33.61M-22.09M
-51.55M-64.38M-49.12M-33.61M-22.09M
254.00K0000
47.75M36.82M33.23M14.99M8.82M
47.75M36.82M33.23M14.99M8.82M